本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.5161
+0.01242.46%
成交量:10.38万
成交额:5.34万
市值:7,432.47万
市盈率:-1.09
高:0.5297
开:0.5052
低:0.5052
收:0.5037
52周最高:10.62
52周最低:0.2950
股本:1.44亿
流通股本:1.20亿
量比:0.33
换手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-0.4752
每股收益(LYR):-0.7570
净资产收益率:-150.82%
总资产收益率:-84.32%
市净率:4.26
市盈率(LYR):-0.68

数据加载中...

2024/03/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

SEC问询函

Form CORRESP - Correspondence
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/22

SEC问询函

Form CORRESP - Correspondence
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/17

重要事件披露

Form 8-K - Current report